MedTrace Logo

Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord

NCT00631670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2012-02-03

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to determine if Stereotactic Body Radiation Therapy (SBRT) is a good way to treat tumors near the spinal cord. Patients will either receive a single treatment or 25 days of treatment given once-a-day, Monday through Friday for about 5 continuous weeks. Our protocol uses life expectancy, patient preference, and tumor size to determine whether SBRT is delivered with 1 or 25 treatments. The single treatment dose is 15 Gy. The 25 treatment group is 70 Gy at 2.8 Gy/treatment.

Conditions

  • Spinal Tumors

Interventions

RADIATION

Stereotactic Body Radiation Therapy

15 Gy in one treatment

RADIATION

Stereotactic Body Radiation Therapy

Dose: 70 Gy at 2.8 Gy/treatment

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Robert J Amdur, MD · University of Florida- Radiation Oncology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2008-10-31
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00631670 on ClinicalTrials.gov